Folate-based thymidylate synthase inhibitors in cancer chemotherapyTakemura, Yuzuru; Jackman, Ann L. · Anti-Cancer Drugs · 1997

Synthesis and biological properties of 3-methyl-10-propargyl-5,8-dideazafolic acidTerence R. Jones; Richard F. Betteridge; David R. Newell; Ann L. Jackman · 1989

The clinical pharmacology of the adenosine deaminase inhibitor 2′-deoxycoformycinJohn F. Smyth; Rosanne M. Paine; Ann L. Jackman; Kenneth R. Harrap; Marvin M. Chassin; Richard H. Adamson; David G. Johns · 1980

The combination of cytotoxic and molecularly targeted therapies – can it be done?Ann L. Jackman; Stanley Kaye; Paul Workman · 2004

Inhibition of Thymidylate Synthase: Biochemical Pharmacology of Drugs with Activity in Colorectal CancerJackman, Ann L. · Tumori Journal · 1997

TomudexTM(ZD1694): from concept to care, a programme in rational drug discoveryAnn L. Jackman; Kenneth R. Harrap; F. Thomas Boyle · 1996

Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthaseWalter H.J. Ward; Rosemary Kimbell; Ann L. Jackman · 1992